ReviewJournal of neurology2025
Efficacy and safety of ublituximab for relapsing multiple sclerosis patients: current evidence and expert opinion.
Paolo Preziosa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it